Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Centrum Medyczne ENEL-MED's 5-Year RORE % for the quarter that ended in Mar. 2026 was 96.30%.
The industry rank for Centrum Medyczne ENEL-MED's 5-Year RORE % or its related term are showing as below:
WAR:ENE's 5-Year RORE % is ranked better than 94.87% of 507
companies
in the Healthcare Providers & Services industry
Industry Median: 2.12
vs WAR:ENE: 96.30
Centrum Medyczne ENEL-MED (WAR:ENE) 5-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Centrum Medyczne ENEL-MED 5-Year RORE % Related Terms
Centrum Medyczne ENEL-MED 5-Year RORE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:ENE vs HCA, THC, DVA: 5-Year RORE % Comparison
For the Medical Care Facilities subindustry, Centrum Medyczne ENEL-MED's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Centrum Medyczne ENEL-MED 5-Year RORE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Centrum Medyczne ENEL-MED's 5-Year RORE % distribution charts can be found below:
* The bar in red indicates where Centrum Medyczne ENEL-MED's 5-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 5-year before.
Centrum Medyczne ENEL-MED (WAR:ENE) has a 5-Year RORE % of 96.30 as of Mar. 2026. 5-Year RORE % shows how much a company earns by reinvesting its retained earnings in 5-year. View historical data on Centrum Medyczne ENEL-MED and its competitors. According to the industry distribution chart, Centrum Medyczne ENEL-MED ranks #26 out of 507 companies in the Healthcare Providers & Services industry, placing it in the top 5.1%.
Is Centrum Medyczne ENEL-MED's 5-Year RORE % too high?
Centrum Medyczne ENEL-MED's current 5-Year RORE % is 96.30. The Healthcare Providers & Services industry median 5-Year RORE % is 2.12. Centrum Medyczne ENEL-MED's value of 96.30 is 4442.5% above this industry median. Based on the distribution chart, Centrum Medyczne ENEL-MED ranks #26 out of 507 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Centrum Medyczne ENEL-MED has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Centrum Medyczne ENEL-MED's 5-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Centrum Medyczne ENEL-MED ranks #26 out of 507 companies for 5-Year RORE %. This places Centrum Medyczne ENEL-MED in the top 5% of its industry — outperforming the majority of peers. The industry median 5-Year RORE % is 2.12. Centrum Medyczne ENEL-MED's value of 96.30 is 4442.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year RORE % for a Healthcare Providers & Services company?
The median 5-Year RORE % among Healthcare Providers & Services companies is 2.12, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Centrum Medyczne ENEL-MED's current 5-Year RORE % of 96.30 is 4442.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year RORE % mean?
A high 5-Year RORE % can signal that a stock is expensive relative to its fundamentals. 5-Year RORE % shows how much a company earns by reinvesting its retained earnings in 5-year. View historical data on Centrum Medyczne ENEL-MED and its competitors. For the Healthcare Providers & Services industry, the median 5-Year RORE % is 2.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Centrum Medyczne ENEL-MED's current 5-Year RORE % is 96.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Centrum Medyczne ENEL-MED stock overvalued right now?
Based on GuruFocus' analysis, Centrum Medyczne ENEL-MED (WAR:ENE) is currently considered Modestly Undervalued. The stock's GF Value™ is zł25.17, compared to a current price of zł19.00 — trading 24.5% below its estimated fair value. The current 5-Year RORE % is 96.30 and 4442.5% above the Healthcare Providers & Services industry median of 2.12. Centrum Medyczne ENEL-MED's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year RORE % calculated?
5-Year RORE % is calculated from a company's financial statements. For Centrum Medyczne ENEL-MED (WAR:ENE), the current 5-Year RORE % is 96.30 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Centrum Medyczne ENEL-MED (WAR:ENE) Overvalued in 2026?
Based on GuruFocus' analysis, Centrum Medyczne ENEL-MED stock appears to be undervalued.
The current stock price of zł19.00 is trading 24.5% below its estimated GF Value™ of zł25.17.
GuruFocus considers Centrum Medyczne ENEL-MED to be Modestly Undervalued.
Key valuation signals for WAR:ENE:
5-Year RORE %: 96.30
GF Value™: zł25.17 vs. price of zł19.00 (24.5% below fair value)
Industry Position: 4442.5% above the Healthcare Providers & Services median (#26 of 507)
No single metric tells the full story. See the WAR:ENE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Centrum Medyczne ENEL-MED SA is engaged in providing medical services throughout Poland region. The company is involved in providing various services that are dentistry, picture diagnosis, clinics, subscription for companies, and medical insurance. It also provides hospitals, aesthetic medicines, and sports medicine. The company's treatment cycle consists of consultation, diagnosis, hospitalization, surgery, and rehabilitation.
78GF Score
Get the complete analysis for WAR:ENE
5-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:ENE has been successfully added to your 
